CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Amoy Diagnostics Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Amoy Diagnostics Co Ltd
No.39, Dingshan Road, Haicang District
Phone: +86 5926806830p:+86 5926806830 XIAMEN, FUJ  361027  China Ticker: 300685300685
Business Summary
Amoy Diagnostics Co Ltd is a China-based company mainly providing tumor gene testing services. The Company mainly operates three businesses. The testing reagent business is engaged in the research, development and production of reagents such as gene mutation detection kits, human microsatellite instability (MSI) detection kits, human B-Raf proto-oncogene (BRAF) V600E mutation detection kits and estrogen receptor antibody reagents. The testing services business mainly provides medical testing services to pharmaceutical companies and research institutions. The drug clinical research services business mainly provides central laboratory testing and companion diagnostic registration services to pharmaceutical companies. The Company is also engaged in the research, development and production of human 12-gene mutation analysis software, as well as supporting instruments such as gene sequencers, fully automated nucleic acid extractors and fully automated immunohistochemical staining machines.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8071 Medical laboratories
7372 Prepackaged software
3826 Laboratory analytical instruments

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board LimouZheng 71 1/29/2021 2/1/2008
Chief Financial Officer, Secretary of the Board YingChen 54 4/29/2021 4/1/2015
General Manager, Director JieminLuo 42 1/8/2025 8/13/2021
10 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,144 (As of 12/31/2024)
Outstanding Shares: 391,536,144 (As of 9/30/2025)
Shareholders: 19,565
Stock Exchange: SHE
Fax Number: +86 5926806203


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, February 4, 2026